edaravone has been researched along with Devic Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, W | 1 |
| Xu, H | 1 |
| Xu, L | 1 |
| Jiang, W | 1 |
| Chen, C | 1 |
| Chang, Y | 1 |
| Liu, C | 1 |
| Tian, Z | 1 |
| Qiu, X | 1 |
| Xie, C | 1 |
| Li, X | 1 |
| Chen, H | 1 |
| Lai, S | 1 |
| Wu, L | 1 |
| Cui, Y | 1 |
| Tang, C | 1 |
| Qiu, W | 1 |
1 other study available for edaravone and Devic Disease
| Article | Year |
|---|---|
Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation.
Topics: Animals; Cell Differentiation; Edaravone; Immunoglobulin G; Mechanistic Target of Rapamycin Complex | 2023 |